TITLE

FDA debates expansion of switch paradigm

AUTHOR(S)
Johnsen, Michael
PUB. DATE
April 2012
SOURCE
Drug Store News;4/23/2012, Vol. 34 Issue 6, p12
SOURCE TYPE
Trade Publication
DOC. TYPE
Opinion
ABSTRACT
The author discusses aspects of the debated proposal by the U.S. Food and Drug Administration (FDA) to expand the switch paradigm of retail pharmacists using communications and diagnostics technology. He explains that this would make prescription products available in over-the-counter (OTC) pharmaceutical services. However, the author thinks that unlocking the technology could open up massive new OTC categories that can surpass compliance standards.
ACCESSION #
76116561

 

Related Articles

  • Government, Law, and Regulation.  // Best Practices for Hospital & Health-System Pharmacy;2007/2008, p139 

    The article presents several laws and regulations on proper pharmaceutical services in the U.S. The Council on Public Policy recommends that boards of pharmacy should adopt regulation that enables the use of telepharmacy services for all practice settings. Moreover, the Food and Drug...

  • Switching things up. JOHNSEN, MICHAEL // Drug Store News;8/25/2014, Vol. 36 Issue 8, p48 

    The article focuses on the status of prescription (Rx) drug-to-over-the-counter (OTC) switches which drives the OTC business. Jim Mackey, senior vice president at pharmaceutical company Merck Consumer Care, mentions that the U.S. Food and Drug Administration (FDA) has new openness to switching...

  • Take your best shot. Plagakis, Jim // Drug Topics;Aug2011, Vol. 155 Issue 8, p18 

    The article addresses the importance of rendering quality pharmaceutical services to patients in the U.S. It states that the Food and Drug Administration (FDA) has ordered pharmaceutical companies to remove prescription drugs for the treatment of colds, cough and allergies. It outlines the role...

  • PhRMA Nixes Changes Suggested for OTC Drug Designation.  // Chemical Market Reporter;07/17/2000, Vol. 258 Issue 3, p21 

    Reports on the plan of the pharmaceutical industry to oppose changes to the regulatory process the United States Food and Drug Administration (FDA) uses for switching prescription drugs to over-the-counter status. Therapeutic drug classes that could face a change in status according to FDA;...

  • FDA issues antidepressant advisory.  // Pharmaceutical Representative;Oct2006, Vol. 36 Issue 10, p11 

    The article reports on the issuance by the U.S. Food and Drug Administration (FDA) of safety warnings against taking triptans together with selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs). The FDA has determined that serotonin...

  • More Funds Needed Abroad. Drakulich, Angie // Pharmaceutical Technology;Jan2008, Vol. 32 Issue 1, p23 

    The article reports on the increased funding needed by the U.S. Food and Drug Administration (FDA) for overseas drug inspection. FDA announces that a total of $16 million is needed for foreign inspection and $56 million is required with the integration of domestic drug inspection. However, it...

  • Process Validation. Levenson, Michele; Chatterjee, Bikash // Pharmaceutical Processing;Jul/Aug2013, Vol. 28 Issue 6, p42 

    The article focuses on the New Process Validation Guidance issued by the U.S. Food and Drug Administration (FDA). Implementing an effective verification and control strategy to ensure process and product performance is important in the new Process Validation Guidance. The new guidance departs...

  • Manufacturers optimistic ahead of FDA review. Houlton, Sarah // Chemical Week;2/19/2003, Vol. 165 Issue 7, p30 

    Reports on the optimism of drug manufacturers on the drug approval rate by the U.S. Food and Drug Administration (FDA) for the year 2003. Goal of the drug review of the FDA; Changes in the pharmaceutical sector; Factors the contributed to the decline of the drug approval rate.

  • TREAT YOURSELF: IS SELF-MEDICATION THE PRESCRIPTION FOR WHAT AILS AMERICAN HEALTH CARE? Noah, Lars // Harvard Journal of Law & Technology;Winter2005, Vol. 19 Issue 2, p359 

    Analyzes the factors that influence the substitution of prescription drugs to over-the-counter status in the U.S. Information on the Federal Food, Drug and Cosmetic Act implemented by the Food and Drug Administration in 1938; Liability consequences of switching prescription drugs into the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics